...
首页> 外文期刊>The Journal of biological chemistry >Threonine eliminylation by bacterial phosphothreonine lyases rapidly causes cross-linking of mitogen-activated protein kinase (MAPK) in live cells
【24h】

Threonine eliminylation by bacterial phosphothreonine lyases rapidly causes cross-linking of mitogen-activated protein kinase (MAPK) in live cells

机译:细菌磷酸苏氨酸裂解酶的苏氨酸消除会迅速引起活细胞中丝裂原激活的蛋白激酶(MAPK)的交联

获取原文
           

摘要

Old long-lived proteins contain dehydroalanine (Dha) and dehydrobutyrine (Dhb), two amino acids engendered by dehydration of serines and threonines, respectively. Although these residues have a suspected role in protein cross-linking and aggregation, their direct implication has yet to be determined. Here, we have taken advantage of the ability of the enteropathogen Shigella to convert the phosphothreonine residue of the pT-X-pY consensus sequence of ERK and p38 into Dhb and followed the impact of dehydration on the fate of the two MAPKs. To that end, we have generated the first antibodies recognizing Dhb-modified proteins and allowing tracing them as they form. We showed that Dhb modifications accumulate in a long-lasting manner in Shigella-infected cells, causing subsequent formation of covalent cross-links of MAPKs. Moreover, the Dhb signal correlates precisely with the activation of the Shigella type III secretion apparatus, thus evidencing injectisome activity. This observation is the first to document a causal link between Dhb formation and protein cross-linking in live cells. Detection of eliminylation is a new avenue to phosphoproteome regulation in eukaryotes that will be instrumental for the development of type III secretion inhibitors.
机译:旧的长寿命蛋白质包含脱氢丙氨酸(Dha)和脱氢丁氨酸(Dhb),这两个氨基酸分别是丝氨酸和苏氨酸脱水产生的。尽管这些残基在蛋白质的交联和聚集中具有怀疑的作用,但它们的直接含义尚待确定。在这里,我们利用了肠病原菌志贺氏菌将ERK和p38的pT-X-pY共有序列的磷酸苏氨酸残基转化为Dhb的能力,并研究了脱水对两个MAPK命运的影响。为此,我们已经产生了第一批识别Dhb修饰蛋白的抗体,并可以追踪它们的形成形式。我们显示Dhb修饰以志贺氏菌感染的细胞中长期积累,导致随后形成MAPKs的共价交联。此外,Dhb信号与志贺氏菌III型分泌设备的激活精确相关,因此证明了注射活性。该观察结果首次证明了Dhb形成与活细胞中蛋白质交联之间的因果关系。消除酰化的检测是真核生物中磷酸化蛋白质组调控的一条新途径,这将有助于III型分泌抑制剂的开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号